| Justin Thomas Kane, PT | |
|
1172 W Hayden Ave, Hayden, ID 83835-8700 | |
| (208) 762-3332 | |
| (208) 762-4268 |
| Full Name | Justin Thomas Kane |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 32 Years |
| Location | 1172 W Hayden Ave, Hayden, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114957073 | NPI | - | NPPES |
| 0000100007419 | Other | ID | BLUE SHIELD |
| 0100472 | Other | WA | WASHINGTON LABOR & INDUST |
| 004401801 | Medicaid | ID | |
| T5501 | Other | ID | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-700 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shellman Inc Pa | 4981592938 | 32 |
| Shellman Inc Pa | 4981592938 | 32 |
News Archive
Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, last week held the latest seminar in its "Innovation for Experimentation" series.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women and one in five men aged over 50 suffer from osteoporotic bone fractures.
The U.S. Food and Drug Administration (FDA) has announced a joint public meeting of the agency's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to be held February 16, 17 and 18, 2005.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
› Verified 8 days ago
| Provider Name | Shellman Inc Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326050253 PECOS PAC ID: 4981592938 Enrollment ID: O20040310000340 |
News Archive
Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, last week held the latest seminar in its "Innovation for Experimentation" series.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women and one in five men aged over 50 suffer from osteoporotic bone fractures.
The U.S. Food and Drug Administration (FDA) has announced a joint public meeting of the agency's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to be held February 16, 17 and 18, 2005.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Thomas Kane, PT 1917 N Lakewood Dr, Coeur D Alene, ID 83814-2634 Ph: (208) 664-8194 | Justin Thomas Kane, PT 1172 W Hayden Ave, Hayden, ID 83835-8700 Ph: (208) 762-3332 |
News Archive
Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, last week held the latest seminar in its "Innovation for Experimentation" series.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women and one in five men aged over 50 suffer from osteoporotic bone fractures.
The U.S. Food and Drug Administration (FDA) has announced a joint public meeting of the agency's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to be held February 16, 17 and 18, 2005.
The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.
› Verified 8 days ago
Laura Handyside Steininger, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8382 N Wayne Dr Ste 204, Hayden, ID 83835 Phone: 208-719-9071 Fax: 208-719-9073 | |
Erica Lea Chvilicek, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8257 N Cornerstone Dr, Hayden, ID 83835 Phone: 208-762-0881 | |
Jeremy Albert Dye, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1172 W Hayden Ave, Hayden, ID 83835 Phone: 208-773-8111 Fax: 208-773-8385 | |
Teri Ann Venera, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8382 N Wayne Dr, Hayden, ID 83835 Phone: 208-758-0484 Fax: 208-485-4781 | |
Adam Michael Borg, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1172 W Hayden Ave, Hayden, ID 83835 Phone: 208-762-3332 Fax: 208-762-4268 | |
Emily Sarah Brown, DPT, OCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8827 N Government Way, Hayden, ID 83835 Phone: 307-699-1716 |